Abstract:Arboviruses represent major challenges to public health, particularly in tropical, and subtropical regions, and a substantial risk to other parts of the world as respective vectors extend their habitats. In recent years, two viruses transmitted by Aedes mosquitoes, Chikungunya and Zika virus, have gathered increased interest. After decades of regionally constrained outbreaks, both viruses have recently caused explosive outbreaks on an unprecedented scale, causing immense suffering and massive economic burdens in affected regions. Chikungunya virus causes an acute febrile illness that often transitions into a chronic manifestation characterized by debilitating arthralgia and/or arthritis in a substantial subset of infected individuals. Zika infection frequently presents as a mild influenza-like illness, often subclinical, but can cause severe complications such as congenital malformations in pregnancy and neurological disorders, including Guillain–Barré syndrome. With no specific treatments or vaccines available, vector control remains the most effective measure to manage spread of these diseases. Given that both viruses cause antibody responses that confer long-term, possibly lifelong protection and that such responses are cross-protective against the various circulating genetic lineages, the development of Zika and Chikungunya vaccines represents a promising route for disease control. In this review we provide a brief overview on Zika and Chikungunya viruses, the etiology and epidemiology of the illnesses they cause and the host immune response against them, before summarizing past and current efforts to develop vaccines to alleviate the burden caused by these emerging diseases. The development of the urgently needed vaccines is hampered by several factors including the unpredictable epidemiology, feasibility of rapid clinical trial implementation during outbreaks and regulatory pathways. We will give an overview of the current developments.

Recent progresses and remaining challenges for the detection of Zika virus

Zika Virus: An Emerging Global Health Threat

The emergence of Zika virus and its new clinical syndromes

Zika virus and diagnostics

Visual detection of Zika virus by isothermal nucleic acid amplification combined with a lateral-flow device

Zika virus: The transboundary pathogen from mosquito and updates.

Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response

Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis

Recent Advances in Animal Models of Zika Virus Infection

Advances in Zika Virus–Host Cell Interaction: Current Knowledge and Future Perspectives

The Zika Virus Infection in Pregnancy: Review and Implications for Research and Care of Women and Infants in Affected Areas

Host and viral mechanisms of congenital Zika syndrome

Production, Titration and Imaging of Zika Virus in Mammalian Cells

A review on Zika vaccine development

Recent advances in the study of zika virus structure, drug targets, and inhibitors

PfAgo-Based Zika Virus Detection

ZIKV viral proteins and their roles in virus-host interactions

Revealing the characteristics of ZIKV infection through tissue-specific transcriptome sequencing analysis

Antiviral Agents in Development for Zika Virus Infections

Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections

Addressing knowledge gaps in molecular, sero-surveillance and monitoring approaches on Zika epidemics and other arbovirus co-infections: A structured review